CD8A and non-small cell lung carcinoma: For non-small cell lung cancer, several studies associated increased CD8 with improved patient outcomes [25,26,27], but others showed no effect on survival [28], or decreased amounts CD8+ infiltrates have been correlated with improved survival [29].